Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Azico Biophore is a strategic joint venture between the Azico Group and Biophore India Pharmaceuticals, specializing in the development and manufacture of high-quality Active Pharmaceutical Ingredients (APIs). The company focuses on niche and complex molecules, including oncology agents, peptides, and iron-based complexes such as Ferric Carboxymaltose. Operating state-of-the-art manufacturing facilities in Visakhapatnam, India, Azico Biophore complies with international regulatory standards including USFDA and EUGMP. The company provides integrated solutions ranging from process development to commercial-scale production, serving global pharmaceutical markets with a focus on highly regulated regions. Their portfolio is designed to address therapeutic areas with high barriers to entry, leveraging advanced chemical synthesis and characterization capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AZICO Biophore India.